Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2003
10/02/2003US20030187200 Comprises nucleotide sequences coding kunitz-type protease inhibitor for treating reproductive, hemostatic and inflammatory disorders
10/02/2003US20030187060 Aminoalkenylbenzoyl-benzofuran or benzothiophene, method for preparing same and compositions containing same
10/02/2003US20030187058 Synergistic mixture of lipoic acid and another fatty acid; antidiabetic agents
10/02/2003US20030187053 Eating disorders; antilipemic agents; anticholesterol agents; cardiovascular disorders
10/02/2003US20030187042 Modulate gene expression; antitumor agents; cardiovascular disorders; anticholesterol agents; antilipemic agents
10/02/2003US20030187040 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
10/02/2003US20030187038 Fibrinogen-lowering agents
10/02/2003US20030187037 Cardiovascular disorders; antiinflammatory agents; antitumor agents
10/02/2003US20030187035 Substituted hydrazones as inhibitors of cyclooxygenase-2
10/02/2003US20030187033 Potassium channel modulators; cardiovascular disorders; antiarrhythmia agents
10/02/2003US20030187024 Vision disorders; antiinflammatory agents; autoimmune disease; anticancer qgents; skin disorders
10/02/2003US20030187023 Sulfone derivatives, process for their production and use thereof
10/02/2003US20030187020 Chemical compounds
10/02/2003US20030187009 Analgesics, diarrhea, anticonvulsants, antitussive agents or drug abuse therapy
10/02/2003US20030187007 Inhibitors of protein kinase for the treatment of disease
10/02/2003US20030187004 Central nervous system disorders; Alzheimer's disease
10/02/2003US20030186996 Angiogenesis inhibitors
10/02/2003US20030186994 Anticholesterol agents; cardiovascular disorders
10/02/2003US20030186989 Antihistamines; respiratory system disorders
10/02/2003US20030186985 Oxyiminoalkanoic acid derivatives
10/02/2003US20030186984 Substituted cyclohexane derivatives
10/02/2003US20030186981 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases
10/02/2003US20030186979 Hydroxyformamidine derivatives and medicines containing the same
10/02/2003US20030186976 Benzofurylpyrone derivatives
10/02/2003US20030186974 Pyrrolyl- and imidazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
10/02/2003US20030186971 Using 1,3-benothiazine compound
10/02/2003US20030186969 Benzodiazepine derivatives
10/02/2003US20030186966 Antiinflammatory agents; autoimmune disease; antiallergens
10/02/2003US20030186964 Piperdines for use as orexin receptor antagonists
10/02/2003US20030186958 Viricides, vision defects, oral diseases, antiarthritic agents, multiple sclerosis, anticancer agents
10/02/2003US20030186952 Anticholesterol agents; cardiovascular disorders
10/02/2003US20030186941 Cyclopenteneone derivatives
10/02/2003US20030186922 Therapeutic use of cis-element decoys in vivo
10/02/2003US20030186896 Crystalline form of perindopril tert-butylamine salt
10/02/2003US20030186894 Dry powder compositions having improved dispersivity
10/02/2003US20030186889 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction
10/02/2003US20030186880 Combination therapy using trefoil peptides
10/02/2003US20030186876 IL-6 antagonist peptides
10/02/2003US20030186865 Pharmaceutical combination for the treatment of tissue damage owing to an arterial irrigation defect
10/02/2003US20030186842 Contacting a cell population with an inhibiting effective amount of a reagent that suppresses the protease activity of at least one member of the interleukin-1beta- converting enzyme (ICE)/CED-3 family
10/02/2003US20030186424 Reagents and methods for identifying and modulating expression of genes regulated by CDK inhibitors
10/02/2003US20030186421 Comprises lipoprotein associated phospholipase A2 (Lp-PLA2) for diagnosing and treating atherosclerosis; enzyme inhibitors
10/02/2003US20030186419 Masp-3, a complement-fixing enzyme, and uses for it
10/02/2003US20030186337 Novel death associated proteins, and THAP1 and PAR4 pathways in apoptosis control
10/02/2003US20030186325 Method of screening for inhibitors of osteopontin
10/02/2003US20030186308 Prostacyclin-stimulating factor-2
10/02/2003US20030186290 Gene involved in CADASIL, method of diagnosis and therapeutic application
10/02/2003US20030186275 Using bacterial peptides to develop vaccine to protect against mycobacterium infections
10/02/2003US20030185909 Composition of traditional chinese medicines for preventing and treating cerebrovascular disease
10/02/2003US20030185890 Compositions and methods for polynucleotide delivery
10/02/2003US20030185888 Volume efficient controlled release dosage form
10/02/2003US20030185860 Administering directly to a blood vessel
10/02/2003US20030185819 Treatment of specific and non-specific inflammation, including asthma; useful in diagnosing and localizing sites of inflammation.
10/02/2003US20030185815 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/02/2003US20030185794 Such as a pleiotrophin or midkine molecule in a pharmaceutically acceptable carrier.
10/02/2003US20030185758 Embolizing a blood vessel by injecting a mixture os polyacrylonitrile, polyvinyl acetate, cellulose acetate butyrate, nitrocellulose, polycarbonate urethane or maleic acid-styrene copolymer; contrast agent and solvent
10/02/2003US20030185756 Carbocyanine dye for visualization, photosensitizer for photodynamic treatment, and tumor receptor-avid peptide for site-specific delivery of the probe and phototoxic agent to diseased tissues
10/02/2003CA2714873A1 Plasma carboxypeptidase b inhibitors
10/02/2003CA2480471A1 A process for the extraction of anthocyanins from black rice and composition thereof
10/02/2003CA2480385A1 Alkoxypyridine derivatives as nitric oxide synthase inhibitors
10/02/2003CA2480384A1 Phenanthridinones as parp inhibitors
10/02/2003CA2480302A1 Compositions and methods for treating and preventing necrosis
10/02/2003CA2480096A1 Process for producing triterpene derivatives
10/02/2003CA2479908A1 Calcineurin activator
10/02/2003CA2479881A1 Hif hydroxylase inhibitors
10/02/2003CA2479880A1 Combination comprising an hmg-coa reductase inhibittor and an insulin secretor enhancer or an insulin sensitizer
10/02/2003CA2479722A1 Combination of an aldosterone receptor antagonist and a fibric acid derivative
10/02/2003CA2479671A1 Combination of an aldosterone receptor antagonist and nicotinic acid for a nicotinic acid derivative
10/02/2003CA2479555A1 Use of cocoa flavanols and oligomers thereof to treat cognitive dysfunction and improve cognitive function in neuro-compromised patients
10/02/2003CA2479383A1 Storage stable eplerenone formulation
10/02/2003CA2479338A1 Substituted phenylacetic acids
10/02/2003CA2479259A1 Combination of an aldosterone receptor antagonist and a bile acid sequestering agent
10/02/2003CA2479256A1 Phosphate prodrugs of fluorooxindoles
10/02/2003CA2478913A1 Substituted chroman derivatives having cytochrome p450rai inhibitory activity
10/02/2003CA2478855A1 Use of il-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases
10/02/2003CA2478839A1 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
10/02/2003CA2478063A1 Lymphatic and blood endothelial cell genes
10/02/2003CA2477651A1 Kinase inhibitors
10/02/2003CA2474637A1 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane nmda, 5ht3, and neuronal nicotinic receptor antagoni sts
10/02/2003CA2451516A1 Agent for preventing or treating diseases caused by enos expression
10/01/2003EP1348709A2 Thiazolo (4,5-D) pyrimidine compounds
10/01/2003EP1348707A1 Pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
10/01/2003EP1348703A1 Polymorph forms of fasidotril, their processes of preparation and pharmaceutical compositions containing them
10/01/2003EP1348698A1 Substituted carboxylic acid derivatives
10/01/2003EP1348697A1 Process for the preparation of S(-)-amlodipine-L(+)-hemitartrate
10/01/2003EP1348440A1 Use of angiotensin 1-7 for enhancing cardiac function
10/01/2003EP1348437A2 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
10/01/2003EP1348434A1 Use of pyridyl amides as inhibitors of angiogenesis
10/01/2003EP1348026A2 Fibrin binding moieties useful as imaging agents
10/01/2003EP1348022A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/01/2003EP1347990A2 Peptide mit inhibierender aktivität zur produktion von stickstoffmonoxid
10/01/2003EP1347987A1 Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
10/01/2003EP1347982A2 Spiro isobenzofuran-1,4'-piperidin]-3-ones and 3h-spiroisobenzofuran-1,4'-piperidines
10/01/2003EP1347981A1 Condensed purine derivatives as a 1? adenosine receptor antagonists
10/01/2003EP1347980A1 Compounds specific to adenosine-a1,-a2a, and- a3-receptor and uses thereof
10/01/2003EP1347979A1 Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands
10/01/2003EP1347974A1 Aminotriazolopyridiine derivatives as adenosine receptor ligands
10/01/2003EP1347972A1 Pyrazolo 3,4-c]pyridines as gsk-3 inhibitors
10/01/2003EP1347971A1 Thiazolyl inhibitors of tec family tyrosine kinases
10/01/2003EP1347966A1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
1 ... 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 ... 1595